Cargando…
Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344967/ https://www.ncbi.nlm.nih.gov/pubmed/37341779 http://dx.doi.org/10.1007/s00277-023-05327-x |
| _version_ | 1785072979723419648 |
|---|---|
| author | Zeidan, Amer M. Pollyea, Daniel A. Borate, Uma Vasconcelos, Alberto Potluri, Ravi Rotter, David Kiendrebeogo, Zephirin Gaugler, Lona Prebet, Thomas Strocchia, Maria Bonifacio, Gaetano Chen, Clara |
| author_facet | Zeidan, Amer M. Pollyea, Daniel A. Borate, Uma Vasconcelos, Alberto Potluri, Ravi Rotter, David Kiendrebeogo, Zephirin Gaugler, Lona Prebet, Thomas Strocchia, Maria Bonifacio, Gaetano Chen, Clara |
| author_sort | Zeidan, Amer M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10344967 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103449672023-07-15 Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States Zeidan, Amer M. Pollyea, Daniel A. Borate, Uma Vasconcelos, Alberto Potluri, Ravi Rotter, David Kiendrebeogo, Zephirin Gaugler, Lona Prebet, Thomas Strocchia, Maria Bonifacio, Gaetano Chen, Clara Ann Hematol Correction Springer Berlin Heidelberg 2023-06-21 2023 /pmc/articles/PMC10344967/ /pubmed/37341779 http://dx.doi.org/10.1007/s00277-023-05327-x Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Zeidan, Amer M. Pollyea, Daniel A. Borate, Uma Vasconcelos, Alberto Potluri, Ravi Rotter, David Kiendrebeogo, Zephirin Gaugler, Lona Prebet, Thomas Strocchia, Maria Bonifacio, Gaetano Chen, Clara Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States |
| title | Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States |
| title_full | Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States |
| title_fullStr | Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States |
| title_full_unstemmed | Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States |
| title_short | Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States |
| title_sort | correction to: venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the united states |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344967/ https://www.ncbi.nlm.nih.gov/pubmed/37341779 http://dx.doi.org/10.1007/s00277-023-05327-x |
| work_keys_str_mv | AT zeidanamerm correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT pollyeadaniela correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT borateuma correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT vasconcelosalberto correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT potluriravi correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT rotterdavid correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT kiendrebeogozephirin correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT gauglerlona correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT prebetthomas correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT strocchiamaria correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT bonifaciogaetano correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates AT chenclara correctiontovenetoclaxplusazacitidinecomparedwithintensivechemotherapyasinductionforpatientswithacutemyeloidleukemiaretrospectiveanalysisofanelectronicmedicalrecorddatabaseintheunitedstates |